Get the app!
Back to Trades
Grant4

Jazz Pharmaceuticals plc

JAZZ

Total Value
$0

Company Information

Ticker Symbol
JAZZ
CIK
0001232524

Insider Information

Role
SVP, Chief Accounting Officer
Officer
Location
DUBLIN 4, L2

Filing Details

Filing Date
Jan 21, 2026
Transaction Date
Jan 16, 2026
Accession Number
0001784606-26-000002
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Jan 16, 2026Ordinary Shares2,370Grant/Award

Footnotes

  1. (F1)Represents ordinary shares of the Issuer that will be delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2023. The performance-based vesting requirements applicable to such awards were satisfied on January 16, 2026, which represents the date on which the level of performance attained was certified.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.